EP1328151A4 - Isolierte nukleinsäuren der p-hyde-familie, p-hyde-proteine und verfahren zur erzeugung von empfindlichkeit gegenüber der induktion des zelltodes in krebs - Google Patents

Isolierte nukleinsäuren der p-hyde-familie, p-hyde-proteine und verfahren zur erzeugung von empfindlichkeit gegenüber der induktion des zelltodes in krebs

Info

Publication number
EP1328151A4
EP1328151A4 EP00953630A EP00953630A EP1328151A4 EP 1328151 A4 EP1328151 A4 EP 1328151A4 EP 00953630 A EP00953630 A EP 00953630A EP 00953630 A EP00953630 A EP 00953630A EP 1328151 A4 EP1328151 A4 EP 1328151A4
Authority
EP
European Patent Office
Prior art keywords
hyde
cancer
proteins
induction
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00953630A
Other languages
English (en)
French (fr)
Other versions
EP1328151A2 (de
Inventor
Mitchell S Steiner
Chiang Wang
Augustinus Rinaldy
Rema Menon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/499,817 external-priority patent/US7043009B1/en
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Publication of EP1328151A2 publication Critical patent/EP1328151A2/de
Publication of EP1328151A4 publication Critical patent/EP1328151A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
EP00953630A 1999-04-29 2000-05-01 Isolierte nukleinsäuren der p-hyde-familie, p-hyde-proteine und verfahren zur erzeugung von empfindlichkeit gegenüber der induktion des zelltodes in krebs Withdrawn EP1328151A4 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US13160799P 1999-04-29 1999-04-29
US30245799A 1999-04-29 1999-04-29
US131607P 1999-04-29
US302457 1999-04-29
US499817 2000-02-08
US09/499,817 US7043009B1 (en) 2000-02-08 2000-02-08 Providing customer data to an automatic call distribution system agent
PCT/US2000/011456 WO2000071564A2 (en) 1999-04-29 2000-05-01 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer

Publications (2)

Publication Number Publication Date
EP1328151A2 EP1328151A2 (de) 2003-07-23
EP1328151A4 true EP1328151A4 (de) 2004-06-16

Family

ID=27384176

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00953630A Withdrawn EP1328151A4 (de) 1999-04-29 2000-05-01 Isolierte nukleinsäuren der p-hyde-familie, p-hyde-proteine und verfahren zur erzeugung von empfindlichkeit gegenüber der induktion des zelltodes in krebs

Country Status (5)

Country Link
EP (1) EP1328151A4 (de)
JP (1) JP2003529321A (de)
AU (1) AU769889B2 (de)
CA (1) CA2371828A1 (de)
WO (1) WO2000071564A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835812B1 (en) 1999-04-29 2004-12-28 University Of Tennessee Research Corporation Human p-Hyde proteins
EP3934661A1 (de) * 2019-03-05 2022-01-12 Dow Global Technologies LLC Induktion von caspase-aktivität
CN113106082B (zh) * 2021-05-27 2022-11-04 云南师范大学 动物粪便宏基因组来源的丙氨酸消旋酶及其制备和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (de) * 1999-07-29 2001-02-07 Helix Research Institute Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
WO2001059127A2 (en) * 2000-02-11 2001-08-16 Incyte Genomics, Inc. Drug metabolizing enzymes
WO2001072962A2 (en) * 2000-03-24 2001-10-04 Fahri Saatcioglu Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0868512B9 (de) * 1995-12-20 2006-09-06 Cerenis Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (de) * 1999-07-29 2001-02-07 Helix Research Institute Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
WO2001059127A2 (en) * 2000-02-11 2001-08-16 Incyte Genomics, Inc. Drug metabolizing enzymes
WO2001072962A2 (en) * 2000-03-24 2001-10-04 Fahri Saatcioglu Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
AMSON R B ET AL: "ISOLATION OF 10 DIFFERENTIALLY EXPRESSED CNDAS IN P53-INDUCED APOPTOSIS: ACTIVATION OF THE VERTEBRATE HOMOLOGUE OF THE DROSOPHILA SEVEN IN ABSENTIA GENE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 9, 30 April 1996 (1996-04-30), pages 3953 - 3957, XP002032914, ISSN: 0027-8424 *
DATABASE EMBL [online] EBI; 22 February 2000 (2000-02-22), "Homo sapiens cDNA FLJ10829 fis, clone NT2RP4001138", XP002276044, retrieved from EMBL Database accession no. AK001691 *
JOHNSON M.I.; HAMDY F.C.: "Apoptosis regulating genes in prostate cancer (Review)", ONCOLOGY REPORTS, vol. 5, no. 3, May 1998 (1998-05-01), pages 553 - 557, XP009028911 *
RINALDY A R ET AL: "Role of pHyde novel gene product as an intrinsic factor for apoptotic pathway in prostate cancer.", GAN TO KAGAKU RYOHO. CANCER & CHEMOTHERAPY. JAPAN MAY 2000, vol. 27 Suppl 2, May 2000 (2000-05-01), pages 215 - 222, XP009028708, ISSN: 0385-0684 *
STEINER M S ET AL: "GROWTH INHIBITION OF PROSTATE CANCER BY AN ADENOVIRUS EXPRESSING A NOVEL TUMOR SUPPRESSOR GENE, PHYDE", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 60, no. 16, 15 August 2000 (2000-08-15), pages 4419 - 4425, XP001076638, ISSN: 0008-5472 *
ZHANG X ET AL: "APOPTOSIS INDUCTION IN PROSTATE CANCER CELLS BY A NOVEL GENE PRODUCT, PHYDE, INVOLVES CASPASE-3", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 20, no. 42, 20 September 2001 (2001-09-20), pages 5982 - 5990, XP008003138, ISSN: 0950-9232 *

Also Published As

Publication number Publication date
EP1328151A2 (de) 2003-07-23
JP2003529321A (ja) 2003-10-07
WO2000071564A8 (en) 2001-10-04
AU769889B2 (en) 2004-02-05
CA2371828A1 (en) 2000-11-30
WO2000071564A3 (en) 2003-05-01
AU6604600A (en) 2000-12-12
WO2000071564A2 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
HUP0200773A2 (hu) Eljárások ráksejt-halál és tumor-regresszió indukálására
EP1244465A4 (de) Induzierung von zellulärer immunantwort gegen prostatakrebsantigenen mittels peptid- und nukleinsäureverbindungen
SI1576132T1 (sl) Nukleinske kisline z oznako 273p4b7 in njihova uporaba pri odkrivanju raka
GB9917307D0 (en) Improvements in and relating to analysis of DNA
HK1152714A1 (en) Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer steap-1
EP1537140A4 (de) Zur behandlung und zum nachweis von krebs geeignete nukleinsäure und zugehöriges protein mit der bezeichnung 161p2f10b
AU3997300A (en) Gene sequence variations with utility in determining the treatment of disease
EP0927270A4 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
AU1186202A (en) Methods of inducing cancer cell death and tumor regression
EP1622571A4 (de) Nucleinsäuren und entsprechende proteine mit der bezeichnung 109p1d4 zur behandlung und zum nachweis von krebs
EP1517606A4 (de) Zur behandlung und zum nachweis von krebs geeignete nukleinsäure und zugehöriges protein mit der bezeichnung 193p1e1b
PT1537140E (pt) Ácido nucleico e proteína correspondente designada 161p2f10b úteis no tratamento e detecção de cancro
EP1590437A4 (de) Für behandlung und nachweis von krebs geeignete nukleinsäuren und entsprechende proteine mit der bezeichnung 254p1d6b
EP1372719A4 (de) Nucleinsäure und entsprechendes protein mit der bezeichnung 125p5c8 zur behandlung und zum nachweis von krebs
EP1186615A4 (de) PROTEIN UND DAFüR KODIERENDE DNS
EP1328151A4 (de) Isolierte nukleinsäuren der p-hyde-familie, p-hyde-proteine und verfahren zur erzeugung von empfindlichkeit gegenüber der induktion des zelltodes in krebs
AU2001285018A1 (en) Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer
EP1573023A4 (de) Nukleinsäure und dieser entsprechendes, 162p1e6 genanntes, für die behandlung und den nachweis von krebs geeignetes protein
AU2003268355A8 (en) Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells
MXPA01010890A (es) Acidos nucleicos aislados de la familia p-hyde, proteinas p-hyde, y metodos para inducir susceptibilidad a la induccion de muerte celular en cancer.
AU3650302A (en) Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
HUP0303890A3 (en) Expression amalysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
AU1576501A (en) Methods to enhance and confine gene expression in cancer therapy
IL156973A0 (en) Mammalian tumor susceptibility gene products and their uses
IL147071A0 (en) Nucleic and proteinic acids corresponding to human gene abc1

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011112

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/861 B

Ipc: 7A 61K 31/7052 B

Ipc: 7C 12Q 1/70 B

Ipc: 7G 01N 33/574 B

Ipc: 7C 07K 16/30 B

Ipc: 7C 12N 15/12 B

Ipc: 7C 07K 14/47 B

Ipc: 7A 01K 67/027 B

Ipc: 7C 12P 21/00 B

Ipc: 7A 61P 35/00 B

Ipc: 7C 07K 19/00 B

Ipc: 7C 07K 16/00 B

Ipc: 7A 61K 48/00 B

Ipc: 7C 07H 21/00 B

Ipc: 7C 12N 15/62 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040504

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080411